2022
DOI: 10.1016/j.idcr.2022.e01611
|View full text |Cite
|
Sign up to set email alerts
|

Detection of viable SARS-CoV-2 in deep respiratory specimens despite negative nasopharyngeal SARS-CoV-2 RT-PCR: Occult COVID-19 as an unsuspected cause of pulmonary infiltrates in immunocompromised patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
9
1

Year Published

2022
2022
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 12 publications
1
9
1
Order By: Relevance
“…Since the beginning of the pandemic, some cases of COVID-19 in patients treated with anti-CD20 monoclonal antibodies (antyCD20mAB) due to haematological illnesses, have been described [ 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 ]. The majority of those patients received rituximab.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Since the beginning of the pandemic, some cases of COVID-19 in patients treated with anti-CD20 monoclonal antibodies (antyCD20mAB) due to haematological illnesses, have been described [ 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 ]. The majority of those patients received rituximab.…”
Section: Discussionmentioning
confidence: 99%
“…The time from the last dose of medication and the infection with SARS-CoV-2 ranged between 2 weeks and 12 months, but in one case it was more than 14 years [ 6 ]. In some patients, the course of COVID-19 was mild at the beginning and they required only observation but after a couple of weeks, they presented to the hospital with symptoms such as elevated body temperature, dyspnoea, and dry cough [ 3 , 7 , 8 , 11 , 12 , 13 ]. Some patients developed respiratory failure during the disease course [ 3 , 4 , 5 , 6 , 7 , 8 , 10 , 11 , 12 , 14 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations